Veterinary Medicines

Zerofen vet, 4%, powder for solution

Authorised
  • Fenbendazole
Download as PDF

Product identification

Medicine name:
Zerofen vet, 4%, powder for solution
Zerofen 4% poeder voor oraal gebruik bij varkens
Active substance:
  • Fenbendazole
Target species:
  • Pig
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Fenbendazole
    40.00
    milligram(s)
    /
    1.00
    gram(s)
Pharmaceutical form:
  • Oral powder
Withdrawal period by route of administration:
  • Oral use
    • Pig
      • Meat and offal
        3
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QP52AC13
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Netherlands
Package description:
  • Bag, 500 g
  • Bag, 5000 g
  • Bag, 10 000 g
  • Bag, 2500 g
  • Bag, 1000 g

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Chanelle Pharmaceuticals Manufacturing Limited
Marketing authorisation date:
Manufacturing sites for batch release:
  • Chanelle Pharmaceuticals Manufacturing Limited
Responsible authority:
  • Medicines Evaluation Board
Authorisation number:
  • REG NL 9952
Date of authorisation status change:
Reference member state:
  • Sweden
Procedure number:
  • SE/V/0110/001
Concerned member states:
  • Belgium
  • Denmark
  • Finland
  • Netherlands
  • Portugal
  • Spain

Documents

Combined File of all Documents

This document does not exist in this language (English). You can find it in another language below.
Dutch (PDF)
Published on: 19/01/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."